Eric Warren - Jul 19, 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Commercial Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Stock symbol
ESPR
Transactions as of
Jul 19, 2023
Transactions value $
-$168
Form type
4
Date filed
7/20/2023, 04:38 PM
Previous filing
Jun 22, 2023
Next filing
Aug 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$168 -106 -0.15% $1.59 69.3K Jul 19, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.